Mr. Mori Arkin is a Co-Founder and serves as Partner at Sphera Funds Management. He is a Co-Founder of Emeritus at Arkin Holdings. Mr. Arkin is one of Israel's most successful life sciences and pharmaceutical entrepreneurs. He headed Agis, growing it into a leading dermatological company in the U.S., until its acquisition by Perrigo in 2005 for $818 million. Mr. Arkin has extensive experience in the development and commercialization of pharmaceutical drug products, having held leadership roles in several companies with significant ties to innovative and generic drug companies. He is also the Owner of Sol-Gel Technologies, a dermatology company. He holds a degree in psychology and philosophy from the Tel Aviv University. He is also an Angel Investor. He served as Board Member at Quiet Therapeutics and Endospan.